The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total HRAS assay is a sandwich immunoassay for quantitative detection of total HRAS in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total HRAS assay is a sandwich immunoassay for quantitative detection of total HRAS in cellular lysates using Alpha Technology.
Loading...
Harvey Rat Sarcoma Viral Oncogene Homolog (HRAS) is a small GTPase that functions as a molecular switch in signal transduction pathways controlling cell proliferation, differentiation, and survival. HRAS cycles between inactive GDP-bound and active GTP-bound states, with activation triggered by receptor tyrosine kinases through guanine nucleotide exchange factors (GEFs). Activated HRAS engages multiple effector pathways including RAF/MEK/ERK, PI3K/AKT, and RAL-GDS cascades. Activating mutations in HRAS, particularly at codons 12, 13, and 61, impair GTPase activity resulting in constitutive signaling and oncogenic transformation. HRAS mutations are found in bladder cancer, head and neck squamous cell carcinoma, and Costello syndrome, a developmental disorder with increased cancer risk. Targeting mutant RAS proteins has been challenging, but recent development of KRAS G12C inhibitors has renewed interest in drugging the RAS family.
The AlphaLISA SureFire Ultra Human and Mouse Total HRAS Detection Kit is a sandwich immunoassay for the quantitative detection of total HRAS in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Ultra kits are compatible with:
AlphaLISA SureFire Ultra kits can be used for:
The Total-AlphaLISA SureFire Ultra assay measures the expression level of a protein target in a cell lysate.
The Total-AlphaLISA SureFire Ultra assay uses two antibodies which recognize two different distal epitopes on the targeted protein. AlphaLISA assays require two bead types: Acceptor and Donor beads. Acceptor beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor beads are coated with streptavidin to capture one of the detection antibodies, which is biotinylated. In the presence of targeted protein, the two antibodies bring the Donor and Acceptor beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor bead, allowing the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Ultra detection reagents. This protocol permits the cells viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Ultra reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining AlphaLISA SureFire Ultra quality.
Specificity of the HRAS Total assay was assessed by evaluating recombinant HRAS, NRAS and KRAS proteins.
Dilutions of NRAS (MyBioSource, MBS143929), HRAS (Abcam, ab61239) and KRAS (Abcam, ab156968) proteins were prepared in Lysis Buffer at the indicated concentrations. HRAS Total levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of protein was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
HRAS Total expression was only detected with HRAS recombinant protein, while no cross-reactivity was observed with NRAS and KRAS proteins. These results demonstrate the specificity of the HRAS Total assay as these three proteins shares approximately 86% sequence identity. Dotted line represents assay background.
HRAS Total protein levels were assessed in HEK293 wild type (WT) and HRAS KO (Abcam, ab260858) cell lines cultured to confluency in T175 flasks.
Each flask was lysed in 3 mL of Lysis Buffer for 10 minutes at RT with shaking. Lysates were serially diluted in Lysis Buffer and evaluated for HRAS Total using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate was transferred into a 384-well white OptiPlate, followed by 5 µL Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
HRAS Total was only detected in WT cells, demonstrating assay specificity. Dotted line represents assay background.
Adherent cells were grown to confluency in T175 flasks at 37°C, 5% CO2, and were lysed with Lysis Buffer at a density of 0.5 x 106 cells/mL. Suspension cells were harvested, washed in HBSS and lysed with Lysis Buffer at 1.6 x 106 cells/mL.
HRAS Total levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of cell lysate (5,000 adherent cells and 16,000 suspension cells) were transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
HRAS is expressed in a wide variety of cell lines. Very high levels of expression were detected in PC3, A549 and A431 cells.
Cell lysate was prepared from HeLa cells cultured to confluence a T175 flask and lysed with Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted in Lysis Buffer and HRAS Total levels were evaluated using the AlphaLISA SureFire Ultra assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect HRAS Total in less than 500 cells/datapoint.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Ultra
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
HRAS
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
Mouse
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.